Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Sustained-release angiopeptin therapy is well tolerated following coronary angioplasty

Aug. 31, 1998

Nicanartine as a possible preventive therapy following angioplasty in coronary artery disease

Aug. 31, 1998

Chronic nepicastat is an effective adjunct therapy for heart failure

Aug. 31, 1998

Phase II study establishes feasibility, safety of pioneering restenosis treatment

Aug. 28, 1998

ETA antagonism with LU-135252 may provide novel antiischemic therapy

Aug. 28, 1998

Bayer reports new agents for treating cardiovascular disease

Aug. 28, 1998

CIBIS-II study results confirm benefits of beta-blockade in heart failure

Aug. 27, 1998

MOXCON study will test the efficacy of SIRAs in treating heart failure

Aug. 27, 1998

News from ACS: PD-180988 is a potent and selective ETA antagonist

Aug. 26, 1998

Pfizer discovers new treatments for atherosclerosis and related disorders

Aug. 26, 1998

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...